A 2-Year Study of an Investigational Drug in Obese Patients (0557-011)
NCT00092859
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1500
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
MK0557
Sponsor
Merck Sharp & Dohme LLC